Author

Cécile L. Tremblay

Unknown affiliation - Cited by 13,849 - HIV - infectious diseases

Biography

Cécile L. Tremblay works at Centre Hospitalier del’Université de Montréal, 3840 rue St-Urbain, Bureau 7-355, Montréal (Qc) H2W 1T8 Canada. His area of research interests includes Infectious diseases, Virology . He /she has authored of many research articles/books in the relevant scope.
Title
Cited by
Year
Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses
A Tauzin, SY Gong, G Beaudoin-Bussières, D Vézina, R Gasser, L Nault, ...Cell host & microbe 30 (1), 97-109. e5, 2022202
67
2022
SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses
D Chatterjee, A Tauzin, L Marchitto, SY Gong, M Boutin, C Bourassa, ...Cell reports 38 (9), 2022202
45
2022
Covid-19 vaccine immunogenicity in people living with HIV-1
L Nault, L Marchitto, G Goyette, D Tremblay-Sher, C Fortin, ...Vaccine 40 (26), 3633-3637, 2022202
35
2022
Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen
M Nayrac, M Dubé, G Sannier, A Nicolas, L Marchitto, O Tastet, A Tauzin, ...Cell Reports 39 (13), 2022202
12
2022
A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses
A Tauzin, SY Gong, D Chatterjee, S Ding, MM Painter, RR Goel, ...Cell reports 41 (4), 2022202
11
2022
Incidence and risk factors for recurrent sexually transmitted infections among MSM on HIV pre-exposure prophylaxis
J Zeggagh, R Bauer, C Delaugerre, D Carette, L Fressard, I Charreau, ...Aids 36 (8), 1129-1134, 2022202
10
2022
Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine
A Tauzin, A Nicolas, S Ding, M Benlarbi, H Medjahed, D Chatterjee, ...Cell Reports 42 (1), 2023202
8
2023
Monkeypox associated myocarditis: a case report
P Brouillard, A Valin-Thorburn, Y Provost, A Chakravarti, G Honos, ...IDCases 30, e0128, 2022202
6
2022
Clonally expanded HIV-1 proviruses with 5′-leader defects can give rise to nonsuppressible residual viremia
Clonally expanded HIV-1 proviruses with ′-leader defects can give rise to nonsuppressible residual viremiaJA White, F Wu, S Yasin, M Moskovljevic, J Varriale, F Dragoni, ...The Journal of clinical investigation 133 (6), 2023202
5
2023
Humoral immune responses against SARS-CoV-2 Spike variants after mRNA vaccination in solid organ transplant recipients
A Tauzin, G Beaudoin-Bussières, SY Gong, D Chatterjee, ...Iscience 2 (9), 2022202
5
2022
Excess BAFF Alters NR4As Expression Levels and Breg Function of Human Precursor-like Marginal Zone B-Cells in the Context of HIV-1 Infection
Excess BAFF Alters NRAs Expression Levels and Breg Function of Human Precursor-like Marginal Zone B-Cells in the Context of HIV-1 InfectionK Doyon-Laliberté, M Aranguren, M Byrns, J Chagnon-Choquet, ...International Journal of Molecular Sciences 23 (23), 1512, 2022202
4
2022
Distinct plasma concentrations of Acyl-CoA-Binding Protein (ACBP) in HIV progressors and elite controllers
S Isnard, L Royston, J Lin, B Fombuena, S Bu, S Kant, T Mabanga, ...Viruses 1 (3), 53, 2022202
4
2022
Risk factors for HIV infection among men who have sex with men in the ANRS IPERGAY PrEP trial
J Gras, M Pillet, G Antoni, E Cua, I Charreau, F Raffi, C Chidiac, J Chas, ...Sexually Transmitted Infections 98 (5), 383-386, 2022202
4
2022
Humoral responses against BQ. 1.1 elicited after breakthrough infection and SARS-CoV-2 mRNA vaccination
A Tauzin, M Benlarbi, H Medjahed, Y Grégoire, J Perreault, ...Vaccines 11 (2), 242, 20220
3
2023
Growth differentiation factor-15 as a biomarker of atherosclerotic coronary plaque: value in people living with and without HIV
L Royston, S Isnard, N Perrin, L Sinyavskaya, C Berini, J Lin, B Trottier, ...Frontiers in cardiovascular medicine 9, 964650, 2022202
3
2022
SARS-CoV-2 Omicron subvariants Spike recognition and neutralization elicited after the third dose of mRNA vaccine
A Tauzin, A Nicolas, S Ding, M Benlarbi, H Medjahed, D Chatterjee, ...medRxiv, 2022.08. 0.2227886, 2022202
3
2022
FoxP3+ CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiation
FoxP+ CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiationA Yero, T Shi, JP Routy, C Tremblay, M Durand, CT Costiniuk, ...Frontiers in Immunology 1, 962912, 2022202
3
2022
Oral vitamin D supplemental therapy to attain a desired serum 25-hydroxyvitamin D concentration in essential healthcare teams
Oral vitamin D supplemental therapy to attain a desired serum 5-hydroxyvitamin D concentration in essential healthcare teamsB Hosseini, CL Tremblay, C Longo, S Glochi, JH White, C Quach, ...Trials 3 (1), 1-11, 0
2
2022
An extended SARS-CoV-2 mRNA vaccine prime-boost interval enhances B cell immunity with limited impact on T cells
An extended SARS-CoV- mRNA vaccine prime-boost interval enhances B cell immunity with limited impact on T cellsA Nicolas, G Sannier, M Dubé, M Nayrac, A Tauzin, MM Painter, RR Goel, ...Iscience 6 (1), 030
2
2023
Hepatitis A and B vaccine uptake and immunisation among men who have sex with men seeking PrEP: a substudy of the ANRS IPERGAY trial
P Le Turnier, I Charreau, A Gabassi, D Carette, L Cotte, G Pialoux, ...Sexually transmitted infections 99 (), 140-14, 030
2
2023

Referred From: https://scholar.google.ca/citations?user=52EPCxIAAAAJ&hl=en

Cited by
Citations 13849
h-index 52
i10-index 176
Recommended Journals
Open Access Journals